(JCI Journals) This month in the JCI, work led by Andrew Tobin at the University of Leicester tested two drugs that specifically target the M1 muscarinic acetylcholine receptor in a mouse model of Alzheimer's disease and discovered that the treatments had promising effects on symptoms of cognitive decline.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2hBlZ0T
No comments:
Post a Comment